Brain-Disabling Treatments in Psychiatry: Drugs, Electroshock, and the Psychopharmaceutical Complex, Second Edition
576
Brain-Disabling Treatments in Psychiatry: Drugs, Electroshock, and the Psychopharmaceutical Complex, Second Edition
576eBook
Related collections and offers
Overview
"Peter Breggin is the conscience of American psychiatry. Once more he updates us on the real evidence with respect to the safety and effectiveness of specific psychiatric medications and ECT. This information is needed by all mental health professionals, as well as patients and families."
--Bertram Karon, Ph.D., Professor of Psychology, Michigan State University, Author of The Psychotherapy of Schizophrenia
-- William Glasser, MD, psychiatrist, author of Reality Therapy
In Brain Disabling Treatments in Psychiatry, renowned psychiatrist Peter R. Breggin, M.D., presents startling scientific research on the dangerous behavioral abnormalities and brain dysfunctions produced by the most widely used and newest psychiatric drugs such as Prozac, Paxil, Zoloft, Cymbalta, Effexor, Xanax, Ativan, Ritalin, Adderall, Concerta, Strattera, Risperdal, Zyprexa, Geodon, Abilify, lithium and Depakote.
Many of Breggin's earlier findings have improved clinical practice, led to legal victories against drug companies, and resulted in FDA-mandated changes in what the manufacturers must admit about their drugs. Yet reliance on these drugs has continued to escalate in the last decade, and drug company interests have overwhelmed psychiatric practice.
This greatly expanded second edition, supported by the latest evidence-based research, shows that psychiatric drugs achieve their primary or essential effect by causing brain dysfunction, and that they tend to do far more harm than good.
- New scientific analyses in this completely updated edition include:
- Chapters covering every new antidepressant and stimulant drug
- Twenty new guidelines for how to conduct non-drug therapy
- A chapter describing how to safely withdraw from psychiatric drugs
- A discussion of "medication spellbinding," explaining how patients fail to appreciate their drug-induced mental dysfunctions
- Documentation of how the drug companies control research and the flow of information about psychiatric treatments
Product Details
| ISBN-13: | 9780826129352 |
|---|---|
| Publisher: | Springer Publishing Company |
| Publication date: | 12/17/2007 |
| Sold by: | Barnes & Noble |
| Format: | eBook |
| Pages: | 576 |
| File size: | 1 MB |
About the Author
Peter R. Breggin, MD, is a Harvard-trained psychiatrist and former full-time consultant at NIMH. He is in private practice in Ithaca, New York, and the author of dozens of scientific articles and more than twenty books.
Read an Excerpt
chapter
Table of Contents
- Preface: A Word About Words
- The Brain-Disabling, Spellbinding Effects of Psychiatric Drugs
- Deactivation Syndrome (Chemical Lobotomy) Caused by Neuroleptics
- Neuroleptic-Induced Anguish, Including Agitation, Despair, and Depression
- Severe and Potentially Irreversible Neurological Syndromes (Tardive Dyskinesia and Neuroleptic Malignant Syndrom) Caused by Neuroleptics
- Neuroleptic-Induced Neurotoxicity, Brain Damage, Persistent Cognitive Deficits, Dementia, and Psychosis
- Recent Developments in Antidepressant Label Changes
- Antidepressant-Induced Mental, Behavioral and Cerebral Abnormalities
- Lithium and Other Drugs for Bipolar Disorder
- Electroconvulsive Therapy (ECT) for Depression
- From Attention-Deficit/Hyperactivity Disorder (ADHD) to Bipolar Disorder: Diagnosing America's Children
- Stimulant-Induced Brain Damage, Brain Dysfunction, and Psychiatric Adverse Reactions
- Antianxiety Drugs, Including Behavioral Abnormalities Caused by Xanax and Halcion
- The Food and Drug Administration (FDA) and the National Institute of Mental Health (NIMH): Drug Company Advocates
- Drug Company Deceptions
- How to More Safely Stop Taking Psychiatric Drugs
- Failed Promises, Last Resorts, and Psychotherapy
Acknowledgments
Introduction: Confirming the Science Behind the First Edition
Appendix: Psychiatric Medications by Category
Bibliography
Index
What People are Saying About This
Praise for the first edition:
"Breggin has written the definitive text for professionals and the public alike who really want to know the hazards, inadequacies and illusions of psychopharmacology. this book will be a foundation for those who specialize in medication-free treatment.
--Kevin F. McCready, PhD, Clinical Director, San Joaquin Psyuchotherapy Center
"This book proves once again that Peter Breggin truly is the 'conscience of American psychiatry.' Breggin shows that the brain-disabling hypothesis of organic psychiatric treatments is overwhelmingly confirmed by clinical experience and the scientific literature. With astounding numbers of elderly, adults, and children on prescribed psychoactive drugs, [this book] should be required reading for all medical interns, practicing physicians, and mental health professionals."
--David Cohen, PhD, Professor of Social Services, University of Montreal
"Once more, Dr. Breggin updates us on the real evidence with respect to the safety and effectiveness of the range of specific psychiatric medications and ECT. This information is needed by all mental health professionals, as well as patients and families, but it is never completely available in textbooks or drug advertising."
--Bertam Karon, PhD, Professor of Psychology, Michigan State University
"Peter Breggin, MD, a scientific-Hippocratic physician, does not for a moment overstate the danger posed by the psychiatric-pharmaceutical cartel."
--Fred A. Baughman, Jr., MD, Fellow, American Academy of Neurology